The reasons for nonfunctional p53/p73 pathways in melanomas and the compromised apoptotic response to chemotherapy include the inactivation of p53/p73 and their pro-apoptotic target genes by deacetylation as well as the expression of antagonistic DNp73 variants. The gene discussed is TP53; the disease is melanoma.